0001615774-19-008214.txt : 20190521 0001615774-19-008214.hdr.sgml : 20190521 20190521205535 ACCESSION NUMBER: 0001615774-19-008214 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190517 FILED AS OF DATE: 20190521 DATE AS OF CHANGE: 20190521 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BIOASIA INVESTMENTS IV LLC CENTRAL INDEX KEY: 0001261786 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36593 FILM NUMBER: 19843870 MAIL ADDRESS: STREET 1: 575 HIGH STREET STREET 2: STE 201 CITY: PALO ALTO STATE: CA ZIP: 984301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BIOASIA MANGEMENT LLC CENTRAL INDEX KEY: 0001227254 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36593 FILM NUMBER: 19843871 MAIL ADDRESS: STREET 1: 575 HIGH ST STREET 2: STE 201 CITY: PALO ALTO STATE: CA ZIP: 94301 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SOLENO THERAPEUTICS INC CENTRAL INDEX KEY: 0001484565 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 770523891 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1235 RADIO ROAD STREET 2: SUITE 110 CITY: REDWOOD CITY STATE: CA ZIP: 94065 BUSINESS PHONE: 650-213-8444 MAIL ADDRESS: STREET 1: 1235 RADIO ROAD STREET 2: SUITE 110 CITY: REDWOOD CITY STATE: CA ZIP: 94065 FORMER COMPANY: FORMER CONFORMED NAME: Capnia, Inc. DATE OF NAME CHANGE: 20100219 4 1 s118477_form4.xml FORM 4 X0306 4 2019-05-17 0 0001484565 SOLENO THERAPEUTICS INC SLNO 0001227254 BIOASIA MANGEMENT LLC 192 LYTTON AVENUE PALO ALTO CA 94301 0 0 1 0 0001261786 BIOASIA INVESTMENTS IV LLC C/O VIVO CAPITAL LLC 192 LYTTON AVENUE PALO ALTO CA 94301 0 0 1 0 Common Stock 2019-05-17 4 S 0 1492 1.98 D 9856 I See Footnote Common Stock 2019-05-20 4 S 0 9856 1.92 D 0 I See Footnote Common Stock 2019-05-17 4 S 0 10434 1.98 D 68942 I See Footnote Common Stock 2019-05-20 4 S 0 68942 1.92 D 0 I See Footnote The shares of common stock are held directly by Biotechnology Development Fund II, L.P. ("BDF II"). BioAsia Management, LLC is the sole general partner of BDF II, and may be deemed to beneficially own the shares of common stock owned by BDF II. BioAsia Management, LLC disclaims beneficial ownership of the shares of Soleno Therapeutics held by BDF II, except to the extent of its pecuniary interest therein. The voting members of BioAsia Management LLC are Frank Kung, Edgar Engleman and Anselm Leung, none of whom has individual voting or investment power with respect to these shares and each of whom disclaims beneficial ownership of such shares. The shares of common stock are held directly by Biotechnology Development Fund IV, L.P., Biotechnology Development Fund IV Affiliates, L.P., and BDF IV Annex Fund, L.P. (collectively, "Vivo Fund IV"). BioAsia Investments IV, LLC is the general partner of Vivo Fund IV and may be deemed to be beneficially own such shares. The voting members of BioAsia Investments IV, LLC are Frank Kung and Edgar Engleman, none of whom has individual voting or investment power with respect to these shares and each of whom disclaims beneficial ownership of such shares. The price reported herein is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.90 to $2.07, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4. The price reported herein is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.89 to $2.07, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (4) to this Form 4. /s/ Frank Kung as a managing member of BioAsia Management, LLC 2019-05-21 /s/ Frank Kung as a managing member of BioAsia Investments IV, LLC, 2019-05-21